This Poster presentation is under embargo until 11 June 2026, as per congress regulations.

Register for email alerts

Publication
  • EHA •
  • 13 June, 2026 •
  • •

Consistency of Response by Baseline Platelet Count in Pacritinib-treated patients in the Real World: MY-PAC Analysis

James Rossetti, Douglas Tremblay, Abiola Oladapo, Michael Marrone, Caleb Paydar, Djibril Liassou, Sarah A. Buckley, Purvi Suthar, Adina Geprifti, Michael Vredenburg , Bruce Feinberg, Naveen Pemmaraju

Publication
  • EHA •
  • 12 June, 2026 •
  • •

Impact of protocol mandated dose holds on platelet response durability in pediatric ITP treated with avatrombopag: AVA 301 post hoc analysis

Rachael F. Grace, Göksel Leblebisatan, Yesim Aydinok, Şule Ünal, John Grainger, Amanda Grimes, Michele Lambert, Jessica Zhang, Brian D. Jamieson, Chelsea Bernheisel, Michael Vredenburg , Faizan Sattar

Publication
  • EHA •
  • 11 June, 2026 •
  • •

Emapalumab in Treatment-Experienced Primary HLH: Safety, Efficacy, and Transplant Outcomes from the Open-Label, Single-Arm Post-Authorization Study Sobi.EMAPALUMAB-104 in Chinese Patients

Rui Zhang, Xiaowen Zhai, Andrew Danquah, Ben Peace, Per Hedlund, Andrew Ramsey, Rafael Krmar, Brian Jamieson

Publication
  • ASH •
  • 8 December, 2025 •
  • •

Patient-reported outcomes of avatrombopag for chronic immune thrombocytopenia: Interim analysis of the Phase 4 adopt study

María Eva Mingot Castellano, María Teresa Álvarez Román, María Luisa Lozano, Wolfgang Miesbach, Hafiz Qureshi, Vickie McDonald, Jessica Zhang, Viridiana Cano Garcia, Nina Skuban

Publication
  • ASH •
  • 6 December, 2025 •
  • •

Real-world safety and efficacy of avatrombopag in adults with immune thrombocytopenia: A systematic review and meta-analysis

María Luisa Lozano, David Valcarcel

Publication
  • ASH •
  • 6 December, 2025 •
  • •

Real-world treatment patterns & outcomes among patients with immune thrombocytopenia (ITP) who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States: Results from the real-AVA 3.5 study

Caroline Piatek, Abiola Oladapo, Scott Kolodny, Michael Vredenburg , Sarah Lucht, Emily Bland, Prathamesh Pathak, Bruce Feinberg, Hillary Maitland

Publication
  • AMCP Nexus •
  • 28 October, 2025 •
  • •

Healthcare Resource Utilization in Patients with Primary Immune Thrombocytopenia Treated with Avatrombopag in the United States: REAL-AVA 2.0 Study Results

Abiola Oladapo, Srikanth Nagalla, Moshe Y Levy, Shruti Chaturvedi, Scott Kolodny, Chelsea Bernheisel, Elyse Swallow, Debbie Goldschmidt, Alexandra Greatsinger, Loren Ormenaj, Sinia Sareen, Michael Vredenburg

Available materials

Poster
Sign up for alerts